79349530 - NEURIMMUNE

Information

  • Trademark
  • 79349530
  • Serial Number
    79349530
  • Registration Number
    7220623
  • Filing Date
    June 27, 2022
    2 years ago
  • Registration Date
    November 21, 2023
    a year ago
  • Transaction Date
    March 18, 2024
    a year ago
  • Status Date
    November 21, 2023
    a year ago
  • Published for Opposition Date
    September 05, 2023
    a year ago
  • Location Date
    November 21, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LEASER, ANDREW C
  • Attorney Name
    Janice Housey
    Law Office Assigned Location Code
    M80
  • Owners
Mark Drawing Code
5000
Mark Identification
NEURIMMUNE
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine and metabolic diseases, circulatory system diseases, eye diseases; veterinary preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine diseases, metabolic diseases, circulatory system diseases, eye diseases; pharmaceutical preparations for immunotherapeutic use, pharmaceutical agents for the elimination of tumors, pharmaceutical preparations for the treatment of neurodegenerative diseases, pharmaceutical preparations, namely, immunogens; pharmaceutical preparations, namely, antibodies used for the testing of the disease; vaccines; diagnostic preparations for medical use in the form of epitopes for detecting protein abnormalities; pharmaceutical preparations, namely, synthetic peptides used for the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biocides; diagnostic preparations for medical or veterinary use; sanitary towels for hygiene purposes; dietetic foods for medical use; dietetic beverages for medical use; biological preparations for medical use in the form of protein antibodies directed against specific protein epitopes for use in the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunological diseases, inflammatory diseases, respiratory diseases, psychological diseases; anti-bacterial preparations, namely, antibacterial substances for medical use, anti-bacterial pharmaceutical preparations, bio-pharmaceutical preparations for the treatment of cancer; protein food supplements
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Medical services; medical services in the field of immunity; providing medical information; medical examinations, namely, physical examinations for medical purposes; pharmaceutical consulting related to the compounding of medicines; wellness and health-related consulting services in the fields of nutrition and diet; consultancy and providing of information in the field of sanitary care, namely, providing of health information in connection with health; veterinary services; beauty salon services; animal care services, namely, veterinary care services; medical consulting services for hygiene in the field of care; medical consultancy and providing of medical information with respect to preparation, administration and dosing of pharmaceutical preparations; medical and pharmaceutical consulting services relating to the preparation of pharmaceutical prescriptions by pharmacists and administration of pharmaceuticals; providing medical information for medical staff and for patients in the form of compiled reports in the field of diagnostic, prophylactic and therapeutic properties of medicines; drug testing, namely, systematic testing of medicinal products for medical use
  • GS0421: Monitoring, inspection and analysis of biologically active chemicals for quality control purposes; research in the field of pharmaceutical products, cosmetics and foodstuffs for others; advisory and information services in the field of monitoring and inspection for the quality control and scientific analysis of biologically active chemicals; research in the field of medical treatment and medical methods; research in the field of biotechnology and antibodies; medical and scientific research in the field of clinical trial review and research with regard to medical treatment; research in the field of sanitary care; monitoring and inspection of biological synthesis and pharmaceutical production for quality control purposes and for purposes of scientific research and research in the field of biology; software design; computer programming; software maintenance; design and development of computer hardware; software development; consultancy and providing of information with respect to quality control of pharmaceutical products; scientific research in the field of cancerous diseases; scientific research with respect to chemistry
Case File Event Statements
  • 3/18/2024 - a year ago
    33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 2/26/2024 - a year ago
    32 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 2/26/2024 - a year ago
    31 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 2/21/2024 - a year ago
    30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 11/21/2023 - a year ago
    29 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 11/21/2023 - a year ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/5/2023 - a year ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/5/2023 - a year ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/4/2023 - a year ago
    25 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 8/16/2023 - a year ago
    24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 8/16/2023 - a year ago
    23 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 8/16/2023 - a year ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/2/2023 - a year ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/1/2023 - a year ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/31/2023 - a year ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/31/2023 - a year ago
    18 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/4/2023 - a year ago
    17 - REFUSAL PROCESSED BY IB Type: RFNP
  • 6/8/2023 - a year ago
    16 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/8/2023 - a year ago
    15 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 4/18/2023 - a year ago
    14 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/17/2023 - a year ago
    13 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/11/2023 - 2 years ago
    12 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/4/2023 - 2 years ago
    11 - CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Type: CORR
  • 11/4/2022 - 2 years ago
    10 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 10/16/2022 - 2 years ago
    9 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 10/7/2022 - 2 years ago
    8 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/7/2022 - 2 years ago
    7 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/7/2022 - 2 years ago
    6 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/7/2022 - 2 years ago
    5 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/7/2022 - 2 years ago
    4 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 9/20/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/16/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/15/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR